89 related articles for article (PubMed ID: 15788696)
1. Coxsackievirus and adenovirus receptor expression on primary osteosarcoma specimens and implications for gene therapy with recombinant adenoviruses.
Graat HC; Wuisman PI; van Beusechem VW; Carette JE; Gerritsen WR; Bras J; Schaap GR; Kaspers GJ; Ogose A; Gu W; Kawashima H; Hotta T
Clin Cancer Res; 2005 Mar; 11(6):2445-7; author reply 2447-8. PubMed ID: 15788696
[No Abstract] [Full Text] [Related]
2. Expression of the coxsackievirus and adenovirus receptor in musculoskeletal tumors and mesenchymal tissues: efficacy of adenoviral gene therapy for osteosarcoma.
Kawashima H; Ogose A; Yoshizawa T; Kuwano R; Hotta Y; Hotta T; Hatano H; Kawashima H; Endo N
Cancer Sci; 2003 Jan; 94(1):70-5. PubMed ID: 12708477
[TBL] [Abstract][Full Text] [Related]
3. High-level expression of the coxsackievirus and adenovirus receptor messenger RNA in osteosarcoma, Ewing's sarcoma, and benign neurogenic tumors among musculoskeletal tumors.
Gu W; Ogose A; Kawashima H; Ito M; Ito T; Matsuba A; Kitahara H; Hotta T; Tokunaga K; Hatano H; Morita T; Urakawa S; Yoshizawa T; Kawashima H; Kuwano R; Endo N
Clin Cancer Res; 2004 Jun; 10(11):3831-8. PubMed ID: 15173092
[TBL] [Abstract][Full Text] [Related]
4. Osteocalcin promoter-based toxic gene therapy for the treatment of osteosarcoma in experimental models.
Ko SC; Cheon J; Kao C; Gotoh A; Shirakawa T; Sikes RA; Karsenty G; Chung LW
Cancer Res; 1996 Oct; 56(20):4614-9. PubMed ID: 8840973
[TBL] [Abstract][Full Text] [Related]
5. [Interleukin 24 inhibits growth and induces apoptosis of osteosarcoma cells MG-63 in vitro and in vivo].
Han Y; Miao J; Sheng W; Wang X; Jing Y; Shan Y; Liu T; Bao W; Yang J
Sheng Wu Gong Cheng Xue Bao; 2009 Oct; 25(10):1538-45. PubMed ID: 20112699
[TBL] [Abstract][Full Text] [Related]
6. Sensitization of osteosarcoma cell line SaOS-2 to chemotherapy by downregulating survivin.
Zou J; Gan M; Mao N; Zhu X; Shi Q; Yang H
Arch Med Res; 2010 Apr; 41(3):162-9. PubMed ID: 20682173
[TBL] [Abstract][Full Text] [Related]
7. Biology and therapy of malignant solid tumors in childhood.
van den Berg H
Cancer Chemother Biol Response Modif; 2002; 20():605-25. PubMed ID: 12703226
[No Abstract] [Full Text] [Related]
8. Epidermal growth factor receptor targeting enhances adenoviral vector based suicide gene therapy of osteosarcoma.
Witlox MA; Van Beusechem VW; Grill J; Haisma HJ; Schaap G; Bras J; Van Diest P; De Gast A; Curiel DT; Pinedo HM; Gerritsen WR; Wuisman PI
J Gene Med; 2002; 4(5):510-6. PubMed ID: 12221644
[TBL] [Abstract][Full Text] [Related]
9. Making gene therapy for osteosarcoma a reality.
Broadhead ML; Clark JC; Choong PF; Dass CR
Expert Rev Anticancer Ther; 2010 Apr; 10(4):477-80. PubMed ID: 20397911
[No Abstract] [Full Text] [Related]
10. Prognostic value of bax, bcl-2, and p53 staining in primary osteosarcoma.
Kaseta MK; Khaldi L; Gomatos IP; Tzagarakis GP; Alevizos L; Leandros E; Papagelopoulos PJ; Soucacos PN
J Surg Oncol; 2008 Mar; 97(3):259-66. PubMed ID: 18161867
[TBL] [Abstract][Full Text] [Related]
11. Ephrin A4 expression in osteosarcoma, impact on prognosis, and patient outcome.
Abdou AG; Abd el-Wahed MM; Asaad NY; Samaka RM; Abdallaha R
Indian J Cancer; 2010; 47(1):46-52. PubMed ID: 20071790
[TBL] [Abstract][Full Text] [Related]
12. Anti-tumor efficacy of a transcriptional replication-competent adenovirus, Ad-OC-E1a, for osteosarcoma pulmonary metastasis.
Li X; Jung C; Liu YH; Bae KH; Zhang YP; Zhang HJ; Vanderputten D; Jeng MH; Gardner TA; Kao C
J Gene Med; 2006 Jun; 8(6):679-89. PubMed ID: 16570242
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of the adenoviral sensitivity of human ovarian cancer cells by transient expression of coxsackievirus and adenovirus receptor (CAR).
Kim JS; Lee SH; Cho YS; Choi JJ; Kim YH; Lee JH
Gynecol Oncol; 2002 May; 85(2):260-5. PubMed ID: 11972385
[TBL] [Abstract][Full Text] [Related]
14. Chemogene therapy: osteocalcin promoter-based suicide gene therapy in combination with methotrexate in a murine osteosarcoma model.
Cheon J; Ko SC; Gardner TA; Shirakawa T; Gotoh A; Kao C; Chung LW
Cancer Gene Ther; 1997; 4(6):359-65. PubMed ID: 9408606
[TBL] [Abstract][Full Text] [Related]
15. [The construction of recombinant adenovirus expressing bifunctional fusion protein sCAR-EGF and the detection of its activity].
Ren PK; Wang F; Li HM; Li ZH; Huang Q
Sheng Wu Gong Cheng Xue Bao; 2006 Sep; 22(5):713-9. PubMed ID: 17037191
[TBL] [Abstract][Full Text] [Related]
16. [Construction of antisense c-myc recombinant adenovirus and its anti-tumor effects on osteosarcoma cell lines MG-63 and U2OS].
Xie XK; Yang DS; Ye ZM; Tao HM
Ai Zheng; 2005 Mar; 24(3):292-7. PubMed ID: 15757529
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of immunohistochemical expression of ezrin in non-metastatic high-grade osteosarcoma.
Ferrari S; Zanella L; Alberghini M; Palmerini E; Staals E; Bacchini P
Pediatr Blood Cancer; 2008 Apr; 50(4):752-6. PubMed ID: 17886294
[TBL] [Abstract][Full Text] [Related]
18. Intranasal therapy with an adenoviral vector containing the murine interleukin-12 gene eradicates osteosarcoma lung metastases.
Worth LL; Jia SF; Zhou Z; Chen L; Kleinerman ES
Clin Cancer Res; 2000 Sep; 6(9):3713-8. PubMed ID: 10999765
[TBL] [Abstract][Full Text] [Related]
19. RANKL expression is related to treatment outcome of patients with localized, high-grade osteosarcoma.
Lee JA; Jung JS; Kim DH; Lim JS; Kim MS; Kong CB; Song WS; Cho WH; Jeon DG; Lee SY; Koh JS
Pediatr Blood Cancer; 2011 May; 56(5):738-43. PubMed ID: 21370405
[TBL] [Abstract][Full Text] [Related]
20. rIL-18 triggered gene therapy based on a transduction with the IL-12 plasmid: a new option as immuno-therapy for osteosarcoma?
Liebau C; Merk H; Roesel C; Schmidt S; Karreman C; Prisack JB; Bojar H; Baltzer AW
Anticancer Res; 2002; 22(5):2559-65. PubMed ID: 12529964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
